iothalamic acid has been researched along with Coronary Artery Disease in 1 studies
Iothalamic Acid: A contrast medium in diagnostic radiology with properties similar to those of diatrizoic acid. It is used primarily as its sodium and meglumine (IOTHALAMATE MEGLUMINE) salts.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Honoris, L | 1 |
| Zhong, Y | 1 |
| Chu, E | 1 |
| Rosenthal, D | 1 |
| Li, D | 1 |
| Lam, F | 1 |
| Budoff, MJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective, Single-Center Double-Blind Randomized Study in Subjects Undergoing Coronary Computed Tomography Angiography (CCTA) Examination (VISIPAQUE Randomized Study)[NCT01534975] | 513 participants (Actual) | Interventional | 2012-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Attenuation (HU) in the ascending aorta, standard deviation (SD) of aorta, will be measured,. (NCT01534975)
Timeframe: 1 year
| Intervention | hounsfield units (Mean) |
|---|---|
| Iodixanol 320 | 333 |
| Iohexol 350 | 357 |
| Iopamidol 370 | 362 |
| Iodixanol 270 | 288 |
1 trial available for iothalamic acid and Coronary Artery Disease
| Article | Year |
|---|---|
Comparison of contrast enhancement, image quality and tolerability in Coronary CT angiography using 4 contrast agents: A prospective randomized trial.
Topics: Aged; Contrast Media; Coronary Angiography; Coronary Artery Disease; Humans; Iohexol; Iothalamic Aci | 2015 |